Zealand Pharma A/S

ZLDPF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$404$7,574-$335-$291
Dep. & Amort.$7$6$6$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$31$32$23$25
Change in WC-$165-$94-$179$134
Other Non-Cash$461$1,001-$15-$55
Operating Cash Flow-$70$8,519-$501-$180
Investing Activities
PP&E Inv.-$1-$6-$6-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$543-$6,160-$2,563-$1,796
Inv. Sales/Matur.$409$4,593$3,127$1,950
Other Inv. Act.$0-$0-$2-$2
Investing Cash Flow-$134-$1,574$555$151
Financing Activities
Debt Repay.$0-$4-$4-$5
Stock Issued$0$27$4$0
Stock Repurch.-$12-$332$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$0$0-$0
Financing Cash Flow-$12-$310-$1-$5
Forex Effect$11-$167-$3$4
Net Chg. in Cash-$205$6,468$50-$31
Supplemental Information
Beg. Cash$1,141$776$726$511
End Cash$937$7,244$776$480
Free Cash Flow-$70$8,513-$510-$183
Zealand Pharma A/S (ZLDPF) Financial Statements & Key Stats | AlphaPilot